Oruka Therapeutics, Inc. ORKA Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance.
The official record: Oruka Therapeutics, Inc.’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent?
- Oruka Therapeutics, Inc. (ORKA) reported effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent of -22.1% in Q4 2025.
- What does effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent mean?
- This metric quantifies the percentage point effect of changes in the deferred tax asset valuation allowance on the effective tax rate. A significant change often signals a shift in management's outlook regarding the company's future profitability and tax planning.